Joe Feldman Email & Phone Number

Cover My Mental Health is a not-for-profit providing individuals with actionable tools toward overcoming insurance obstacles to mental health and substance use (MH/SUD) care.

From Louisiana’s robust, country food with French and Southern influences, to the polished tastes of New Orleans, we offer the seasonings and fixings you need to create authentic, vibrant, and simply delicious foods. Our brands include Cajun’s Choice and Rajun’ Cajun.

Evanston Partners, LLC is a private equity investment firm which partners with management teams to recapitalize, acquire and build small growth companies. We seek to work with partners who demonstrate passion, integrity and strong work ethic and to build already profitable companies with a long term focus on value creation

Chicago Capital Partners is a diversified, Chicago-based private equity holding company looking to develop long-term business partnerships. We seek to make equity investments in profitable, well-managed businesses. This unique structure and investor group allows a “go-anywhere” approach when evaluating potential investments and affords flexibility in investment time horizon, investment and return requirements, and type of investment. This further enables investments through a variety of customized structures in lower middle market companies looking for a long-term equity partner. www.chicagocapitalpartners.com

Businesses include Spex (specialty optical retailer) and OGI (design and distribution of eyewear).

Information technology support for small/medium-sized businesses

Planegg, De

Clients include private equity-owned companies (portfolio companies of, among others, GTCR, ABRY Partners, W Capital, Oaktree Capital, TPG Capital), public companies, privately-held firms, and lower middle market private equity investors (including Mason Wells, Hammond Kennedy Whitney, Silver Oak Services Partners).Please visit www.josephfeldman.com for a recap of selected client projects, as well as publications offering insights for companies to be successful with acquisitions.

Featured leader of faculty workshops on entrepreneurial finance, value proposition, channel-to-market, and venture validation. Directed graduate student consulting teams’ assessment of commercial potential of UICfaculty inventions across numerous healthcare and engineering disciplines. Projects included developments in: water treatment, anti-microbial therapeutics, maternal health, cancer diagnostics and therapeutics, and specialized medical devices. Recommendations presented to Illinois Ventures and the UIC Office of Technology Management.

Co-developed commercialization assessment program for faculty invention winners of the UIC Chancellor's Innovation Fund Proof of Concept Award. Co-developed launch plans for and co-led implementation of Chicago Innovation Mentors, a team mentoring initiative co-sponsored with Northwestern University, the University of Illinois at Chicago, and iBIO. Co-authored successful grant funding proposal supporting the program. Initiated portfolio review of University of Chicago research and intellectual property for major pharmaceutical company, resulting in funding of oncology research program.

Chicago, Illinois, Us

Co-founded Sandbox, recruited teams, and implemented strategies for new business ideation, business concept evaluation, investment proposition development, seed stage funding decisions, and ongoing evaluation of new business potential and path to liquidityEstablished operations and teams for launches of Morgan Street Document Systems (personal document management), Embodi (nutritional beverage), A Fresh Squeeze (environmental e-newsletter), and pre-launch projects in Sandbox’s areas of interestServed on board of directors or other advisory capacity for all portfolio companiesCOO of portfolio company, delivering first major customer contract, new technology in-license, expansion of operating team, and investors for $5 million Series A financingParticipated in fund-raising for Sandbox Industries, Sandbox Ventures, and three portfolio companies, resulting in total investments over $30 millionCo-led operational start-up of Sandbox Ventures, including legal documentation, investor presentations, and recruitment of placement agent to support fund-raising

Secured letter of intent with Syngenta for 2-year, multi-million-dollar corn technology development collaborationEstablished strategic negotiations with DuPont/Pioneer for development collaboration in maize and evaluation of equity investmentReached definitive agreement with Illinois Soybean Association and University of Illinois for a 3-year, 100% grower-funded research program of company technology in soybeansConceived and created integrated program at Saskatoon, Saskatchewan for internal development program in canola, as well as external canola program with BASF

Us

Negotiated development collaborations with GlaxoSmithKline and Memorial Sloan Kettering, resulting in revenue of $3 million and co-development of genetic banking programsEstablished marketing collaboration with Quintiles Transnational, resulting in significant access to Big Pharma deal-flow and $3 million equity investment (at increased valuation).

Identified incremental $150-200 million value in R&D discovery pipeline for inflammatory bowel disease, resulting in significant out-licensing opportunityLed negotiations with two leading biotechnology research technology providers, resulting in the completion of a 3-year access agreement for supply of animal modelsInitiated merger integration preparations for R&D technology in-licensing, oncology business development, and meetings/conventions groups, resulting in identification of post-merger leverage for six major R&D relationships and $15 million in annual operating savings

St. Louis, Missouri, Us

Led negotiations to create food biotechnology joint venture between Monsanto Company and Cargill Inc. with value projected at $800 million Developed valuation and strategic rationale for acquisition of leading flavor company ($1+ billion bid) and leading soy-based ingredients company ($1+ billion bid). Both lost to pre-emptive bids far in excess of value to MonsantoEstablished three-year global acquisition program, resulting in evaluation of 20 properties, and completion of 7 transactions with combined value of $60 millionLed Monsanto-wide evaluation of technological and commercial potential in nutritional food arena, resulting in establishment of Monsanto’s Nutrition Sector and investment program of $40 million/year against key targets for cardiovascular and cancer nutrition

Augusta, Georgia, Us

Established three-year global acquisition program, resulting in evaluation of 20 properties, and completion of 7 transactions with combined value of $60 millionLed Monsanto-wide evaluation of technological and commercial potential in nutritional food arena, resulting in establishment of Monsanto’s Nutrition Sector and investment program of $40 million/year against key targets for cardiovascular and cancer nutritionSecured investment of $5 million in order fulfillment systems, resulting in profit increase of $2.5 million annually and in solidifying relationships with Wal*Mart, Kmart and other operationally-sophisticated customersCompleted strategic assessment of flavor industry including North American and European acquisition targets, resulting in decision to discontinue flavor industry focus in favor of other food ingredient properties; purchase of $1.1 billion texturizer firm followed in 1995Secured regulatory approval for NutraSweet in the Soviet Union and negotiated barter financing with Moscow customer and third-country trader, resulting in NutraSweet sales of over $1 million just 18 months after initial exploratory visit

Mba

Bs, Finance

Diploma